Clinical Trials Browser

Completed × ceralasertib × Tumor-Agnostic × Clear all

NCT02630199 2022-06-15

Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer

Phase 1 Completed

Neoplasms